190 related articles for article (PubMed ID: 38066874)
21. Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
Boissel N; Baruchel A
Blood; 2018 Jul; 132(4):351-361. PubMed ID: 29895662
[TBL] [Abstract][Full Text] [Related]
22. Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.
O'Dwyer K; Freyer DR; Horan JT
Blood; 2018 Jul; 132(4):362-368. PubMed ID: 29895667
[TBL] [Abstract][Full Text] [Related]
23. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
Muffly L; Yin J; Jacobson S; Wall A; Quiroz E; Advani AS; Luger SM; Tallman MS; Litzow MR; Foster MC; Erba HP; Appelbaum FR; Larson RA; Keegan THM; Stock W
Blood Adv; 2022 Jul; 6(14):4085-4092. PubMed ID: 35838753
[TBL] [Abstract][Full Text] [Related]
24. Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis.
Namjoshi NS; Keegan THM; Li QC; Chung JH; Rosenthal JL; Winestone LE; Muffly L; Malogolowkin MH; Alvarez EM
Leuk Lymphoma; 2022 Dec; 63(13):3191-3199. PubMed ID: 35999808
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloid leukemia in adolescents and young adults: from the viewpoint of pediatricians].
Tomizawa D; Adachi S
Rinsho Ketsueki; 2017; 58(8):1038-1046. PubMed ID: 28883267
[TBL] [Abstract][Full Text] [Related]
26. A qualitative study of barriers and facilitators to adolescents and young adults' participation in cancer clinical trials: Oncologist and patient perspectives.
Abrahão R; Alvarez EM; Waters AR; Romero CC; Gosdin MM; Naz H; Pollock BH; Kirchhoff AC; Keegan THM
Pediatr Blood Cancer; 2022 Apr; 69(4):e29479. PubMed ID: 34913583
[TBL] [Abstract][Full Text] [Related]
27. AYA Considerations for Aggressive Lymphomas.
Llaurador G; Giulino-Roth L
Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
[TBL] [Abstract][Full Text] [Related]
28. Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population-based study.
Schulpen M; Goemans BF; Kaspers GJL; Raaijmakers MHGP; Zwaan CM; Karim-Kos HE
Int J Cancer; 2022 Apr; 150(7):1101-1112. PubMed ID: 34913161
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic approaches to hematological malignancies in adolescents and young adults].
Sekimizu M
Rinsho Ketsueki; 2018; 59(10):2273-2283. PubMed ID: 30305536
[TBL] [Abstract][Full Text] [Related]
30. Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study.
Mobley EM; Charlton ME; Ward MM; Lynch CF
Cancer; 2019 Jul; 125(13):2283-2290. PubMed ID: 30901085
[TBL] [Abstract][Full Text] [Related]
31. Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
Shimony S; Flamand Y; Valtis YK; Place AE; Silverman LB; Vrooman LM; Brunner AM; Sallan SE; Stone RM; Wadleigh M; Neuberg DS; DeAngelo DJ; Luskin MR
Blood Adv; 2023 Sep; 7(18):5234-5245. PubMed ID: 37432068
[TBL] [Abstract][Full Text] [Related]
32. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
33. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective.
Derwich K; Brzezinski A; Karpenko C; Morar V; Atukoralalage U
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):1-5. PubMed ID: 34232789
[TBL] [Abstract][Full Text] [Related]
34. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO; Parsons SK; Wroblewski KE; Chen L; Hong F; Smith SM; McNeer JL; Advani RH; Gascoyne RD; Constine LS; Horning S; Bartlett NL; Shah B; Connors JM; Leonard JI; Kahl BS; Kelly KM; Schwartz CL; Li H; Friedberg JW; Friedman DL; Gordon LI; Evens AM
Cancer; 2018 Jan; 124(1):136-144. PubMed ID: 28902390
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and risk factors of bloodstream infections among adolescents and young adults with acute lymphoblastic leukaemia: An 11-year retrospective cohort study.
Xue L; Tang Y; Wang L; Xu C; Cheng Q; Li X
Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13850. PubMed ID: 38452755
[TBL] [Abstract][Full Text] [Related]
36. Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL).
Bleyer A
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101322. PubMed ID: 34865694
[TBL] [Abstract][Full Text] [Related]
37. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia.
Rotz SJ; Wei W; Thomas SM; Hanna R
Cancer; 2020 Dec; 126(24):5319-5327. PubMed ID: 32910494
[TBL] [Abstract][Full Text] [Related]
38. Adolescents and young adults with acute lymphoblastic leukemia.
Stock W
Hematology Am Soc Hematol Educ Program; 2010; 2010():21-9. PubMed ID: 21239766
[TBL] [Abstract][Full Text] [Related]
39. Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia.
Hayashi H; Volt F; Sanz J; Petersen E; Dhedin N; Hough R; Milpied N; Angelucci E; Yakoub-Agha I; Michallet M; Michel G; Aljurf M; Kenzey C; Rocha V; Dalle JH; Bader P; Ruggeri A; Gluckman E;
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2438-2446. PubMed ID: 31394275
[TBL] [Abstract][Full Text] [Related]
40. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Rosenberg SM; McCue S; He J; Lafky JM; Carey LA; Galanis E; Leonard JP; Meyerhardt J; Ng K; Schwartz GK; Stock W; Paskett ED; Partridge AH; George S
Cancer; 2024 Mar; 130(5):750-769. PubMed ID: 37916800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
